A Master Clinical Trial Agreement (MCTA) is a foundational contract that sets standardized legal and business terms for multiple studies between a sponsor and an institution.
It establishes baseline provisions for confidentiality, indemnification, intellectual property, payment terms, and operational responsibilities, reducing repetitive negotiations for each new trial. Study-specific details are typically handled through addenda, work orders, or individual study agreements. In clinical research operations, MCTAs can shorten startup timelines and improve consistency across trial portfolios. Clear master terms also strengthen compliance by standardizing expectations for oversight, documentation, and responsibilities across studies.